Dow Up 1.31% Nasdaq Up 2.40%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.71 Down 0.00(0.45%) 4:00PM EDT
Prev Close:0.72
Open:0.70
Bid:0.65 x 30000
Ask:0.74 x 2000
1y Target Est:3.50
Beta:0.94
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:0.70 - 0.72
52wk Range:0.65 - 4.00
Volume:156,395
Avg Vol (3m):328,103
Market Cap:43.19M
P/E (ttm):N/A
EPS (ttm):-0.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCDown 0.45%43.19M
AGENUp 0.67%188.04M
DNDNDown 2.65%170.97M
STMLDown 2.73%166.36M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback